Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer.
Mol Ther
; 29(11): 3258-3273, 2021 11 03.
Article
in En
| MEDLINE
| ID: mdl-33974998
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Carrier Proteins
/
RNA Editing
/
Gene Targeting
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Ther
Journal subject:
BIOLOGIA MOLECULAR
/
TERAPEUTICA
Year:
2021
Type:
Article
Affiliation country:
Singapore